Morphic Therapeutic, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 2015-01-01
- Employees
- 101
- Market Cap
- $2.8B
- Website
- http://www.morphictx.com
Clinical Trials
10
Active:2
Completed:3
Trial Phases
2 Phases
Phase 1:3
Phase 2:7
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Phase 2
7 (70.0%)Phase 1
3 (30.0%)A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Phase 2
Recruiting
- Conditions
- Inflammatory Bowel DiseasesCrohn's Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2024-01-26
- Last Posted Date
- 2025-09-02
- Target Recruit Count
- 210
- Registration Number
- NCT06226883
- Locations
- 🇺🇸
Gastro Care Institute, Lancaster, California, United States
🇺🇸IHS Health Research, Kissimmee, Florida, United States
🇺🇸Louisiana Research Center, Shreveport, Louisiana, United States
A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC
Phase 2
Active, not recruiting
- Conditions
- Inflammatory Bowel DiseasesColitis, Ulcerative
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-11-10
- Last Posted Date
- 2025-08-29
- Target Recruit Count
- 282
- Registration Number
- NCT05611671
- Locations
- 🇺🇸
Arizona Digestive Health - Sun City, Sun City, Arizona, United States
🇺🇸Gastro Care Institute, Lancaster, California, United States
🇺🇸TLC Clinical Research Inc., Los Angeles, California, United States
A Phase 2a Open-Label Study to Evaluate the Efficacy and Safety of MORF-057 in Adults With UC
- First Posted Date
- 2022-03-23
- Last Posted Date
- 2025-08-14
- Target Recruit Count
- 39
- Registration Number
- NCT05291689
- Locations
- 🇵🇱
Clinical Study Site, Łódź, Poland
Study of MORF 057 to Evaluate Single and Multi Ascending Doses in Healthy Volunteers
- First Posted Date
- 2020-10-08
- Last Posted Date
- 2025-08-01
- Target Recruit Count
- 67
- Registration Number
- NCT04580745
- Locations
- 🇺🇸
Medpace, Cincinnati, Ohio, United States
News
No news found